Enter assignee name

% Expired Patents = 100.0

Forward Citations = 66

Loading Chart...

26 inventors (with patents filed for the assignee):

Yimin Qian (2 out of 73 patents)

Weiya Yun (2 out of 20 patents)

Adrian Wai-Hing Cheung (2 out of 15 patents)

4. Fariborz Firooznia (2 out of 31 patents)

5. David Robert Bolin (2 out of 22 patents)

6. Lee Apostle McDermott (2 out of 9 patents)

7. Matthew Michael Hamilton (2 out of 59 patents)

8. Raymond Tabibiazar (1 out of 6 patents)

9. Jenny Tan (1 out of 9 patents)

10. Thomas Quertermous (1 out of 3 patents)

11. Cesare Mondadori (1 out of 7 patents)

12. Shiming Li (1 out of 1 patent)

13. Melisa Cooper (1 out of 1 patent)

14. Mustapha Abarghaz (1 out of 1 patent)

15. Stefano Biondi (1 out of 6 patents)

5 patents: Sort by Forward Citations

1. 8058299 - Diacylglycerol acyltransferase inhibitors (2011-11-15),

2. 7714126 - Diacylglycerol acyltransferase inhibitors (2010-05-11),

3. 7495024 - Phenylalkyl N-hydroxyureas for combating atherosclerotic plaque (2009-02-24),

4. 7410963 - Benzo-1,4-diazepin-2-one derivatives as phosphodiesterase PDE2 inhibitors, preparation and therapeutic use thereof (2008-08-12),

5. 7250410 - Cyclic nucleotide phosphodiesterase inhibitors, preparation and uses thereof (2007-07-31),

Via Pharmaceuticals, Inc. is a biotechnology company focused on developing novel therapies for cardiovascular and metabolic diseases. Their innovative approach integrates cutting-edge research in drug discovery with a deep understanding of disease mechanisms to create targeted treatments that improve patient outcomes. With a commitment to scientific excellence and a passion for improving patient care, Via Pharmaceuticals is dedicated to bringing new, effective therapies to market.

Profile summary based on public USPTO records.